Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion
- 31 January 2009
- journal article
- Published by Elsevier in Developmental & Comparative Immunology
- Vol. 33 (1) , 105-116
- https://doi.org/10.1016/j.dci.2008.07.006
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Opportunities for New Therapies Based on the Natural Regulators of Complement ActivationAnnals of the New York Academy of Sciences, 2005
- Recombinant cobra venom factorMolecular Immunology, 2004
- Cobra venom factor: an intact $beta;-chain is not required for activityMolecular Immunology, 1993
- Activation of the Alternative Complement Pathway Accompanies Disease Flares in Systemic Lupus Erythematosus During PregnancyArthritis & Rheumatism, 1992
- Suppression of the Immune Response by a Soluble Complement Receptor of B LymphocytesScience, 1991
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989
- Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.Journal of Clinical Investigation, 1982
- Molecular characterization of the complement activating protein in the venom of the Indian cobra (Naja n. siamensis)Molecular Immunology, 1981
- Reaction Mechanisms of β1H GlobulinInternational Archives of Allergy and Immunology, 1978
- Cobra Venom Factor: Evidence for Its Being Altered Cobra C3 (the Third Component of Complement)Science, 1976